Who Owns Neuropace Stock?
NASDAQ: NPCEHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 94.19%
- Held by insiders
- 4.45%
- Institutional holders
- 153
- Institutions 94.2%
- Insiders 4.4%
- Public and other 1.4%
Who owns Neuropace stock?
Institutional investors own about 94.2% of Neuropace's shares, spread across 153 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 4.45% of NPCE.
The largest institutional holders are First Light Asset Management, LLC (11.56%), Polar Capital Holdings PLC (9.57%) and Soleus Capital Management, L.P. (9.34%). Together, the top 10 institutions control 60.9% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their NPCE positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NPCE
| Institution | Shares | % Held | Change |
|---|---|---|---|
| First Light Asset Management, LLC | 3.98M | 11.56% | +39.2% |
| Polar Capital Holdings PLC | 3.30M | 9.57% | 0.0% |
| Soleus Capital Management, L.P. | 3.22M | 9.34% | +10.5% |
| Morgan Stanley | 2.57M | 7.46% | -3.2% |
| Blackrock Inc. | 2.47M | 7.16% | -0.4% |
| Driehaus Capital Management, LLC | 1.43M | 4.15% | -1.2% |
| Vanguard Capital Management LLC | 1.23M | 3.58% | +0.6% |
| Orbimed Advisors LLC. | 1.06M | 3.06% | -29.9% |
| Deutsche Bank AG | 935.65K | 2.72% | -0.3% |
| Armistice Capital, LLC | 800.00K | 2.32% | +15.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NPCE
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 908.48K | 2.64% |
| iShares Trust-iShares Russell 2000 ETF | 692.15K | 2.01% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 290.40K | 0.84% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 288.06K | 0.84% |
| iShares Trust-iShares Russell 2000 Growth ETF | 241.05K | 0.70% |
| BlackRock Funds-BlackRock Advantage Small Cap Core Fund | 227.09K | 0.66% |
| Driehaus Mutual Funds-Driehaus Micro Cap Growth Fund | 175.10K | 0.51% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 151.95K | 0.44% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 121.43K | 0.35% |
| RBB Fund, Inc.-Adara Smaller Companies Fund | 84.79K | 0.25% |
Frequently asked questions
Who is the largest shareholder of Neuropace?
First Light Asset Management, LLC is the largest institutional shareholder of NPCE, owning 11.56% of shares outstanding (3.98M shares) as of its latest 13F filing.
What percentage of Neuropace is owned by institutions?
Institutions own about 94.2% of NPCE shares and 98.6% of the public float.
How much of Neuropace do insiders own?
Insiders, such as officers and directors, own about 4.45% of NPCE shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.